Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma

Human Gene Therapy

Volumn 10, Issue 6, 1999, Pages 889-898

  Park, Bernard J ^a   Brown, Charles K ^a   Hu, Yun ^a   Alexander, H Richard ^a   Horti, Jozsef ^a   Raje, Sangeeta ^a   Figg, William D ^a   Bartlett, David L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 METHYLPURINE; 6 METHYLPURINE DEOXYRIBOSIDE; MONOPHENOL MONOOXYGENASE; PRODRUG; PURINE NUCLEOSIDE PHOSPHORYLASE; UNCLASSIFIED DRUG;

ARTICLE; CELL KILLING; CELL MEDIATED CYTOTOXICITY; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; DNA TRANSFECTION; ENHANCER REGION; ESCHERICHIA COLI; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE THERAPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MELANOMA CELL; PROMOTER REGION; TISSUE SPECIFICITY;

ANIMALS; BASE SEQUENCE; CELL SURVIVAL; CYTOMEGALOVIRUS; DNA PRIMERS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOCYTES; MELANOMA, EXPERIMENTAL; MICE; MONOPHENOL MONOOXYGENASE; PROMOTER REGIONS (GENETICS); PURINE NUCLEOSIDES; PURINE-NUCLEOSIDE PHOSPHORYLASE; UP-REGULATION;

EID: 0033541593     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018292     Document Type: Article

References (42)

1. BENTLEY, N.J., EISEN, T., and CODING, C.R. (1994). Melanocyte-specific expression of the human tyrosinase promoter: Activation by the microphthalmia gene product and role of the initiator. Mol. Cell. Biol. 14, 7996-8006.
2. BRODY, S.L., JAFFE, H.A., HAN, S.K., WERSTO, R.P., and CRYSTAL, R.G. (1994). Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors. Hum. Gene Ther. 5, 437-447.
3. CHEN, H., EGAN, J.O., and CHIU, J.F. (1997). Regulation and activities of alpha-fetoprotein. Crit. Rev. Eukaryotic Gene Expression 7, 11-41.
4. CHEN, S.H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G., and WOO, S.L. (1994). Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. U.S.A. 91, 3054-3057.
5. CRISTIANO, R.J., and ROTH, J.A. (1996). Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Ther. 3, 4-10.
6. DA COSTA, L.T., JEN, J., HE, T.C., CHAN, T.A., KINZLER, K.W., and VOGELSTEIN, B. (1996). Converting cancer genes into killer genes. Proc. Natl. Acad. Sci. U.S.A. 93, 4192-4196.
7. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
8. FUJIWARA, T., GRIMM, E.A., MUKHOPADHYAY, T., ZHANG, W.W., OWEN-SCHAUB, L.B., and ROTH, J.A. (1994). Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res. 54, 2287-2291.
9. GANSS, R., MONTOLIU, L., MONAGHAN, A.P., and SCHUTZ, G. (1994). A cell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice. EMBO J. 13, 3083-3093.
10. GIEBEL, L.B., STRUNK, K.M., and SPRITZ, R.A. (1991). Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment. Genomics 9, 435-445.
11. HART, I.R. (1996). Tissue specific promoters in targeting systemically delivered gene therapy. Semin. Oncol. 23, 154-158.
12. HUBER, B.E., RICHARDS, C.A., and KRENITSKY, T.A. (1991). Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 88, 8039-8043.
13. HUBER, B.E., AUSTIN, E.A., GOOD, S.S., KNICK, V.C., TIBBELS, S., and RICHARDS, C.A. (1993). In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53, 4619-4626.
14. HUGHES, B.W., WELLS, A.H., BEBOK, Z., GADI, V.K., GARVER, R.I., JR., PARKER, W.B., and SORSCHER, E.J. (1995). Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res. 55, 3339-3345.
15. HUGHES, B.W., KING, S.A., ALLAN,. P.W., PARKER, W.B., and SORSCHER, E.J. (1998). Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase. J. Biol. Chem. 273, 2322-2328.
16. IDO, A., NAKATA, K., KATO, Y., NAKAO, K., MURATA, K., FUJITA, M., ISHII, N., TAMAOKI, T., SHIKU, H., and NAGATAKI, S. (1995). Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene expression. Cancer Res. 55, 3105-3109.
17. KANEKO, S., HALLENBECK, P., KOTANI, T., NAKABAYASHI, H., MCGARRITY, G., TAMAOKI, T., ANDERSON, W.F., and CHIANG, Y.L. (1995). Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res. 55, 5283-5287.
18. KASAHARA, N., DOZY, A.M., and KAN, Y.W. (1994). Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373-1376.
19. KESARI, S., RANDAZZO, B.P., VALYI-NAGY, T., HUANG, Q.S., BROWN, S.M., MACLEAN, A.R., LEE, V.M., TROJANOWSKI, J.Q., and FRASER, N.W. (1995). Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant. Lab. Invest. 73, 636-648.
20. KLUPPEL, M., BEERMANN, F., RUPPERT, S., SCHMID, E., HUMMLER, E., and SCHUTZ, G. (1991). The mouse tyrosinase promoter is sufficient for expression in melanocytes and in the pigmented epithelium of the retina. Proc. Natl. Acad. Sci. U.S.A. 88, 3777-3781.
21. KRASNYKH, V., DMITRIEV, I., MIKHEEVA, G., MILLER, C.R., BELOUSOVA, N., and CURIEL, D.T. (1998). Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J. Virol. 73, 1844-1852.
22. LEE, E.R., MARSHALL, J., SIEGEL, C.S., JIANG, C., YEW, N.S., NICHOLS, M.R., NEITUPSKI, J.B., ZIEGLER, R.J., LANE, M.B., WANG, K.X., WAN, N.C., SCHEULE, R.K., HARRIS, D.J., SMITH, A.E., and CHENG, S.H. (1996). Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. 7, 1701-1717.
23. LEE, R.J., and HUANG, L. (1996). Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271, 8481-8487.
24. LOWINGS, P., YAVUZER, U., and GODING, C.R. (1992). Positive and negative elements regulate a melanocyte-specific promoter. Mol. Cell. Biol. 12, 3653-3662.
25. MANOME, Y., ABE, M., HAGEN, M.F., FINE, H.A., and KUFE, D.W. (1994). Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir. Cancer Res. 54, 5408-5413.
26. OSAKI, T., TANIO, Y., TACHIBANA, I., HOSOE, S., KUMAGAI, T., KAWASE, I., OIKAWA, S., and KISHIMOTO, T. (1994). Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res. 54, 5258-5261.
27. PANG, S., DANNULL, J., KABOO, R., XIE, Y., TSO, C.L., MICHEL, K., DEKERNION, J.B., and BELLDEGRUN, A.S. (1997). Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. Cancer Res. 57, 495-499.
28. PARKER, W.B., KING, S.A. ALLAN, P.W., BENNETT, L.L., JR., SECRIST, J.A., MONTGOMERY, J.A., GILBERT, K.S., WAUD, W.R., WELLS, A.H., GILLESPIE, G.Y., and SORSCHER, E.J. (1997). In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase. Hum. Gene Ther. 8, 1637-1644.
29. RICHARDS, C.A., AUSTIN, E.A., and HUBER, B.E. (1995a). Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene Ther. 6, 881-893.
30. RICHARDS, C.A., AUSTIN, E.A., and HUBER, B.E. (1995b). Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene Ther. 6, 881-893.
31. RODRIGUEZ, R., SCHUUR, E.R., LIM, H.Y., HENDERSON, G.A., SIMONS, J.W., and HENDERSON, D.R. (1997). Prostate attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57, 2559-2563.
32. SCHUUR, E.R., HENDERSON, G.A., KMETEC, L.A., ILLER, J.D., AMPARSKI, H.G., and HENDERSON, D.R. (1996). Prostate-specific antigen expression is regulated by an upstream enhancer. J. Biol. Chem. 271, 7043-7051.
33. SCHWARZENBERGER, P., SPENCE, S.E., GOOYA, J.M., MICHIEL, D., CURIEL, D.T., RUSCETTI, F.W., and KELLER, J.R. (1996). Targeted gene transfer to human hematopoietic progenitor cell lines through the c-Kit receptor. Blood 87, 472-478.
34. SHIBATA, K., MURAOSA, Y., TOMITA, Y., TAGAMI, H., and SHIBAHARA, S. (1992). Identification of a cis-acting element that enhances the pigment cell-specific expression of the human tyrosinase gene. J. Biol. Chem. 267, 20584-20588.
35. SIDERS, W.M., HALLORAN, P.J., and FENTON, R.G. (1996). Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells. Cancer Res. 56, 5638-5646.
36. SMITH, M.J., ROUSCULP, M.D., GOLDSMITH, K.T., CURIEL, D.T., and GARVER, R.I., JR. (1994). Surfactant protein A-directed toxin gene kills lung cancer cells in vitro. Hum. Gene Ther. 5, 29-35.
37. SOMIA, N.V., ZOPPE, M., and VERMA, I.M. (1995). Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery. Proc. Natl. Acad. Sci. U.S.A. 92, 7570-7574.
38. SORSCHER, E.J., PENG, S., BEBOK, Z., ALLEN, P.W., BENNETT, L.L., JR., and PARKER, W.B. (1994). Tumor cell bystander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines. Gene Ther. 1, 233-238.
39. TANAKA, T., KANAI, F., OKABE, S., YOSHIDA, Y., WAKIMOTO, H., HAMADA, H., SHIRATORI, Y., LAN, K., ISHITOBI, M., and OMATA, M. (1996). Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. Cancer Res. 56, 1341-1345.
40. VILE, R.G., and HART, I.R. (1993a). In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res. 53, 962-967.
41. VILE, R.G., and HART, I.R. (1993b). Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res. 53, 3860-3864.
42. YASUMOTO, K., YOKOYAMA, K., SHIBATA, K., TOMITA, Y., and SHIBAHARA, S. (1994). Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol. Cell. Biol. 14, 8058-8070. [Published erratum appears in Mol. Cell. Biol. 1995; 15(3): 1833]